128 related articles for article (PubMed ID: 27752511)
1.
Eleftheriadou I; Manolaras I; Irvine EE; Dieringer M; Trabalza A; Mazarakis ND
Ann Clin Transl Neurol; 2016 Oct; 3(10):752-768. PubMed ID: 27752511
[TBL] [Abstract][Full Text] [Related]
2. Muscle-derived but not centrally derived transgene GDNF is neuroprotective in G93A-SOD1 mouse model of ALS.
Li W; Brakefield D; Pan Y; Hunter D; Myckatyn TM; Parsadanian A
Exp Neurol; 2007 Feb; 203(2):457-71. PubMed ID: 17034790
[TBL] [Abstract][Full Text] [Related]
3. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
[TBL] [Abstract][Full Text] [Related]
4. IGF-1:tetanus toxin fragment C fusion protein improves delivery of IGF-1 to spinal cord but fails to prolong survival of ALS mice.
Chian RJ; Li J; Ay I; Celia SA; Kashi BB; Tamrazian E; Matthews JC; Bronson RT; Rossomando A; Pepinsky RB; Fishman PS; Brown RH; Francis JW
Brain Res; 2009 Sep; 1287():1-19. PubMed ID: 19563785
[TBL] [Abstract][Full Text] [Related]
5. Improved lentiviral transduction of ALS motoneurons in vivo via dual targeting.
O'Leary VB; Ovsepian SV; Bodeker M; Dolly JO
Mol Pharm; 2013 Nov; 10(11):4195-206. PubMed ID: 24066863
[TBL] [Abstract][Full Text] [Related]
6. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
[TBL] [Abstract][Full Text] [Related]
7. Olfactory ensheathing cell transplantation into spinal cord prolongs the survival of mutant SOD1(G93A) ALS rats through neuroprotection and remyelination.
Li Y; Bao J; Khatibi NH; Chen L; Wang H; Duan Y; Huang H; Zhou C
Anat Rec (Hoboken); 2011 May; 294(5):847-57. PubMed ID: 21416627
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
9. Autocrine production of IGF-I increases stem cell-mediated neuroprotection.
Lunn JS; Sakowski SA; McGinley LM; Pacut C; Hazel TG; Johe K; Feldman EL
Stem Cells; 2015 May; 33(5):1480-9. PubMed ID: 25532472
[TBL] [Abstract][Full Text] [Related]
10. Venezuelan equine encephalitis virus glycoprotein pseudotyping confers neurotropism to lentiviral vectors.
Trabalza A; Georgiadis C; Eleftheriadou I; Hislop JN; Ellison SM; Karavassilis ME; Mazarakis ND
Gene Ther; 2013 Jul; 20(7):723-32. PubMed ID: 23171919
[TBL] [Abstract][Full Text] [Related]
11. Intraspinal cord delivery of IGF-I mediated by adeno-associated virus 2 is neuroprotective in a rat model of familial ALS.
Franz CK; Federici T; Yang J; Backus C; Oh SS; Teng Q; Carlton E; Bishop KM; Gasmi M; Bartus RT; Feldman EL; Boulis NM
Neurobiol Dis; 2009 Mar; 33(3):473-81. PubMed ID: 19135533
[TBL] [Abstract][Full Text] [Related]
12. The retrograde delivery of adenovirus vector carrying the gene for brain-derived neurotrophic factor protects neurons and oligodendrocytes from apoptosis in the chronically compressed spinal cord of twy/twy mice.
Uchida K; Nakajima H; Hirai T; Yayama T; Chen K; Guerrero AR; Johnson WE; Baba H
Spine (Phila Pa 1976); 2012 Dec; 37(26):2125-35. PubMed ID: 22648027
[TBL] [Abstract][Full Text] [Related]
13. The lack of effect of specific overexpression of IGF-1 in the central nervous system or skeletal muscle on pathophysiology in the G93A SOD-1 mouse model of ALS.
Messi ML; Clark HM; Prevette DM; Oppenheim RW; Delbono O
Exp Neurol; 2007 Sep; 207(1):52-63. PubMed ID: 17597610
[TBL] [Abstract][Full Text] [Related]
14. Autophagy activation and neuroprotection by progesterone in the G93A-SOD1 transgenic mouse model of amyotrophic lateral sclerosis.
Kim J; Kim TY; Cho KS; Kim HN; Koh JY
Neurobiol Dis; 2013 Nov; 59():80-5. PubMed ID: 23891729
[TBL] [Abstract][Full Text] [Related]
15. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
[TBL] [Abstract][Full Text] [Related]
16. Highly Efficient and Selective CAR-Gene Transfer Using CD4- and CD8-Targeted Lentiviral Vectors.
Jamali A; Kapitza L; Schaser T; Johnston ICD; Buchholz CJ; Hartmann J
Mol Ther Methods Clin Dev; 2019 Jun; 13():371-379. PubMed ID: 30997367
[TBL] [Abstract][Full Text] [Related]
17. Monitoring CAR T cell generation with a CD8-targeted lentiviral vector by single-cell transcriptomics.
Charitidis FT; Adabi E; Thalheimer FB; Clarke C; Buchholz CJ
Mol Ther Methods Clin Dev; 2021 Dec; 23():359-369. PubMed ID: 34729382
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis.
Nardo G; Iennaco R; Fusi N; Heath PR; Marino M; Trolese MC; Ferraiuolo L; Lawrence N; Shaw PJ; Bendotti C
Brain; 2013 Nov; 136(Pt 11):3305-32. PubMed ID: 24065725
[TBL] [Abstract][Full Text] [Related]
19. Olesoxime delays muscle denervation, astrogliosis, microglial activation and motoneuron death in an ALS mouse model.
Sunyach C; Michaud M; Arnoux T; Bernard-Marissal N; Aebischer J; Latyszenok V; Gouarné C; Raoul C; Pruss RM; Bordet T; Pettmann B
Neuropharmacology; 2012 Jun; 62(7):2346-52. PubMed ID: 22369784
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of JGK-263 in transgenic SOD1-G93A mice of amyotrophic lateral sclerosis.
Ahn SW; Jeon GS; Kim MJ; Shon JH; Kim JE; Shin JY; Kim SM; Kim SH; Ye IH; Lee KW; Hong YH; Sung JJ
J Neurol Sci; 2014 May; 340(1-2):112-6. PubMed ID: 24680562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
